- 英文名称
- Methylprednisolone hemisuccinate
- 分子式
- C26H34O8
- 分子量
- 474.54
- 中文别名
- 4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-二羟基-6,10,13-三甲基-3-氧代-6,7,8,9,10,11,12,13,14,15,16,17-十二氢-3H-环戊烷并[a]菲-17-基)-2-氧代乙氧基)-4-氧代丁酸; 甲基泼尼松龙琥珀酸; 琥珀酸甲泼尼龙; 甲基泼尼松杂质15; 甲基强的松龙21-半琥珀酸酯; 甲基泼尼松龙琥珀酸酯/甲基泼尼松龙琥珀酸/甲级泼尼松琥珀醋酸酯/泼尼松龙琥珀酸酯; 泼尼松龙琥珀酸酯; 甲基泼尼松龙半琥珀酸酯; 甲级泼尼松琥珀醋酸酯; 4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid; 6a-Methylprednisolone 21-Hemisuccinate; Urbason-Soluble; Butanedioic acid, mono[(6α,11β)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl] ester; 4-{[(6α,11β)-11,17-Dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoic acid; Methylprednisolone hydrogen succinate; Solumedrol; 6-methylprednisolone-21-hemisuccinate; methylprednisolone hemisuccinate esters; methylprednisolone succinate; 6α-Methylprednisolone 21-HeMisuccinate; 6-alpha-Methyl Isomer of Methylhydrocortisone 21-Hydrogen Succinate; 11β,17,21-Trihydroxy-6α-methylpregna-1,4-diene-3,20-dione 21-succinate; 6.alpha.-Methylprednisolone 21-hemisuccinate
- 用途
- 作为糖皮质激素,用于治疗严重过敏反应、哮喘、自身免疫疾病、血液病、胃肠道疾病、内分泌障碍等;临床用于危重病人急性期和危重期及急救后维持治疗,包括呼吸道疾病、内分泌失调、风湿性疾病、胶原性疾病、过敏反应、神经系统疾病、胃肠道疾病、皮肤病、脏器移植后排异反应等对症治疗,也作为免疫抑制剂治疗肿瘤、休克等